Surgery Websites
LiverSource »  Faculty »  Hepatology »  Bilal Hameed, MBBS

Bilal Hameed, MBBS

  • Professor of Medicine
  • Hepatology and Liver Transplantation
  • Department of Medicine

Contact Information

Academic Office
 Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Phone: (415) 514-2860
415-476-0659
[email protected]
Open Popup

Education

1995-2000 Dow Medical College, M.B.B.S.

 

Residencies

  • 2003-2006 University of Minnesota, Minneapolis, Internal Medicine Residency

Fellowships

  • 2006-2009 University of Minnesota, Minneapolis, Gastroenterology Fellowship

  • 2009-2010 University of California, San Francisco, Transplant Hepatology Fellowship

Board Certifications

  • American Board of Internal Medicine
  • American Board of Internal Medicine - Gastroenterology

Program Affiliations

  • UCSF Liver Transplantation Program

Clinical Expertise

Research Interests

  • Epidemiology and management of NAFLD
  • Modeling outcomes in advanced liver disease and liver transplantation.
  • Sleep apnea in NAFLD

Biography

Bilal Hameed, M.D. is an Assistant Professor of Medicine and hepatologist at UCSF who treats patients with liver disease and plays an integral role in the multidisciplinary Liver Transplantation Program.

Dr. Hameed received his medical degree from Dow Medical College, completed an internal medicine residency at the University of Minnesota, and consecutive fellowships at the University of Minnesota and UCSF, in the areas of gastroenterology and transplant hepatology respectively. Dr. Hameed is board certified by the American Board of Internal Medicine with a general certificate in internal medicine and a subspeciality in gastroenterology.

Dr. Hameed is a member of American Association for the Study of Liver Diseases, American Gastroenterological Association. and American Society of Transplantation. He is author of numerous peer-reviewed articles and the recipient of many awards and honors in his field. He is also fluent languages of  Punjabi and Urdu.

Clinical Trials

Data provided by UCSF Profiles, powered by CTSI

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 53
Data provided by UCSF Profiles, powered by CTSI
  1. Sanyal AJ, Williams SA, Lavine JE, Neuschwander-Tetri BA, Alexander L, Ostroff R, Biegel H, Kowdley KV, Chalasani N, Dasarathy S, Diehl AM, Loomba R, Hameed B, Behling C, Kleiner DE, Karpen SJ, Williams J, Jia Y, Yates KP, Tonascia J. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease. J Hepatol. 2023 04; 78(4):693-703. View in PubMed
  2. Trauner M, Bowlus CL, Gulamhusein A, Hameed B, Caldwell SH, Shiffman ML, Landis C, Muir AJ, Billin A, Xu J, Liu X, Lu X, Chung C, Myers RP, Kowdley KV. Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC. Clin Gastroenterol Hepatol. 2023 06; 21(6):1552-1560.e2. View in PubMed
  3. Rao A, Rule JA, Hameed B, Ganger D, Fontana RJ, Lee WM. Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry. Am J Gastroenterol. 2022 04 01; 117(4):617-626. View in PubMed
  4. Kwong A, Hameed B, Syed S, Ho R, Mard H, Arshad S, Ho I, Suleman T, Yao F, Mehta N. Machine learning to predict waitlist dropout among liver transplant candidates with hepatocellular carcinoma. Cancer Med. 2022 03; 11(6):1535-1541. View in PubMed
  5. Mazzini GS, Augustin T, Noria S, Romero-Marrero C, Li N, Hameed B, Eisenberg D, Azagury DE, Ikramuddin S. ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis. Surg Obes Relat Dis. 2022 Mar; 18(3):314-325. View in PubMed
  6. View All Publications

 

 
Site Directory
    X